News
DOACs’ safety affirmed in real-world setting
July 9, 2018
Direct oral anticoagulants were linked with lower bleeding risk, regardless of reason for use. One shone brightest.
News
ICH: Recent NOAC use associated with lower risk of in-hospital mortality, compared with warfarin
July 9, 2018
Among patients presenting with an intracerebral hemorrhage (ICH), what is the association between recent anticoagulant use and in-hospital mortality?
News
New look at ATLAS suggests rivaroxaban may still have role in ACS
July 2, 2018
A reanalysis of the ATLAS ACS 2-TIMI 51 trial separated fatal and nonfatal events.
News
Myeloproliferative neoplasms increase risk for arterial and venous thrombosis
July 2, 2018
What are the risks for arterial and venous thrombosis in patients with myeloproliferative neoplasms (MPNs)?
News
RBC transfusions with surgery may increase VTE risk
June 14, 2018
Stricter blood management practices and VTE prophylaxis may be needed if the study findings are confirmed.
News
DOAC’s edge over warfarin fades with low adherence
June 12, 2018
BOSTON – When atrial fib patients adhere to a direct oral anticoagulant it outperforms warfarin, but when compliance falls the tables get turned.
News
Skip the catheter-directed thrombolytics
May 30, 2018
Does the addition of catheter-directed thrombolysis to standard therapy with anticoagulation reduce the risk of the postthrombotic syndrome in proximal DVT?
News
LAAC in nonvalvular AF provides stroke protection comparable to warfarin
May 24, 2018
Is mechanical left atrial appendage closure (LAAC) as effective as warfarin at preventing stroke in patients with nonvalvular atrial fibrillation?
News
Design limitations may have compromised DVT intervention trial
May 14, 2018
WASHINGTON – The preferred evaluation – intravascular ultrasound – was not used.
News
First reversal agent for apixaban and rivaroxaban gets fast-track approval
May 4, 2018
Andexanet alfa approval puts factor Xa inhibitors in the same ballpark as dabigatran, reversible with idarucizumab.